Related references
Note: Only part of the references are listed.Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological malignancies
Hiroto Inaba et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Pegylated arginase I: a potential therapeutic approach in T-ALL
Claudia P. Hernandez et al.
BLOOD (2010)
Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13
Steven L. Highfill et al.
BLOOD (2010)
Phosphorylation of eIF2α at Serine 51 Is an Important Determinant of Cell Survival and Adaptation to Glucose Deficiency
Hala Muaddi et al.
MOLECULAR BIOLOGY OF THE CELL (2010)
Adult T-cell leukemia-lymphoma: current treatment strategies and novel immunological approaches
Ryuji Tanosaki et al.
EXPERT REVIEW OF HEMATOLOGY (2010)
Inhibition of eIF2α Dephosphorylation Maximizes Bortezomib Efficiency and Eliminates Quiescent Multiple Myeloma Cells Surviving Proteasome Inhibitor Therapy
Denis M. Schewe et al.
CANCER RESEARCH (2009)
Arginase I-Producing Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma Are a Subpopulation of Activated Granulocytes
Paulo C. Rodriguez et al.
CANCER RESEARCH (2009)
Adaptive suppression of the ATF4-CHOP branch of the unfolded protein response by toll-like receptor signalling
Connie W. Woo et al.
NATURE CELL BIOLOGY (2009)
Amino Acid Addiction
J. Magarian Blander et al.
SCIENCE (2009)
Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia
Steven M. Chan et al.
BLOOD (2007)
L-arginine availability regulates T-lymphocyte cell-cycle progression
Paulo C. Rodriguez et al.
BLOOD (2007)
Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion
Paul Ning-Man Cheng et al.
CANCER RESEARCH (2007)
Pegylated arginine deiminase treatment of patients with metastatic melanoma: Results from phase I and II studies
PA Ascierto et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Translational control in stress and apoptosis
M Holcik et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
A selective inhibitor-of eIF2α dephosphorylation protects cells from ER stress
M Boyce et al.
SCIENCE (2005)
Amino acids as regulators of gene expression: molecular mechanisms
C Jousse et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital
CH Pui et al.
BLOOD (2004)
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia
AP Weng et al.
SCIENCE (2004)
Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: Results from phase I/II studies
F Izzo et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Inhibition of a constitutive translation initiation factor 2α phosphatase CReP, promotes survival of stressed cells
C Jousse et al.
JOURNAL OF CELL BIOLOGY (2003)
New ways of initiating translation in eukaryotes?
R Schneider et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Internal ribosome entry sites in eukaryotic mRNA molecules
CUT Hellen et al.
GENES & DEVELOPMENT (2001)
Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2α
I Novoa et al.
JOURNAL OF CELL BIOLOGY (2001)
Share Paper
